NT
Nutriband Inc.
NTRB · NASDAQ
$6.65 +7.69% (+$0.48)
1M +9.38%
Market Cap $75.1M
P/E Ratio -
Div. Yield -
ROE 109.02%
Bulios Fair Price
$4.42
33.5% downside
Current Price
$6.65
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NTRB is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 14.09x
P/S 46.40x
EV/FFO N/A
Growth
13 /100
Declining Book val. growth 7.98%
Rev. growth 0.69%
FCF growth N/A
Profitability
13 /100
Weak Op. margin 435.58%
Gross margin 33.14%
FCF margin 224.55%
Quality
3 /100
Poor ROA 110.64%
ROIC 127.00%
Asset turnover 0.26x
Debt
69 /100
Low Int. coverage -550.70x
Debt/Equity 0.04x
Current ratio 4.21x
Stability
33 /100
Unstable EPS volatility 74.94%
Beta 2.04x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NTRB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gareth Sheridan
Employees
13
Headquarters
Orlando
Upcoming events
07 DEC
Earnings
Upcoming earnings report